Allworth Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73K Sell
109
-37
-25% -$875 ﹤0.01% 4244
2025
Q4
$3.85K Buy
146
+6
+4% +$131 ﹤0.01% 3862
2025
Q3
$2.39K Buy
140
+18
+15% +$258 ﹤0.01% 3919
2025
Q2
$1.53K Buy
122
+12
+11% +$143 ﹤0.01% 3815
2025
Q1
$1.38K Buy
110
+76
+224% +$1.04K ﹤0.01% 3350
2024
Q4
$499 Hold
34
﹤0.01% 3601
2024
Q3
$427 Hold
34
﹤0.01% 3454
2024
Q2
$333 Hold
34
﹤0.01% 3472
2024
Q1
$358 Hold
34
﹤0.01% 3369
2023
Q4
$354 Buy
+34
New +$271 ﹤0.01% 3202
2022
Q3
Sell
-92
Closed 3163
2022
Q2
$0 Hold
92
﹤0.01% 2879
2022
Q1
$1K Sell
92
-22
-19% -$196 ﹤0.01% 2041
2021
Q4
$2K Hold
114
﹤0.01% 1762
2021
Q3
$3K Hold
114
﹤0.01% 1634
2021
Q2
$4K Hold
114
﹤0.01% 1283
2021
Q1
$4K Hold
114
﹤0.01% 1205
2020
Q4
$5K Buy
+114
New +$5.29K ﹤0.01% 1006

Other funds holding ZYME

Allworth Financial's ZYME Position: Q1 2026 in Review

Allworth Financial reduced its Zymeworks (ZYME) stake by 25% in Q1 2026, selling an estimated $875 and leaving 109 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #4244.

Allworth Financial first reported a position in ZYME in Q4 2020 and has held it in 17 quarters since. The position peaked at $5K in Q4 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Allworth Financial held 109 shares of Zymeworks worth $2.73K as of Q1 2026.
  • Allworth Financial sold 37 Zymeworks shares in Q1 2026, an estimated $875.
  • Zymeworks made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4244 holding.
  • Allworth Financial first reported a position in Zymeworks in Q4 2020 and has held it in 17 quarters since.
  • Allworth Financial's Zymeworks position peaked at $5K in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.